ad

Torrent Pharmaceuticals Share Price Gains 1.91% After Q1 Results

Torrent Pharmaceuticals gains 1.91% to Rs 4,965.00. Q1 FY27 PAT Rs 566 crore vs Rs 548 crore (+3.3% YoY). Revenue Rs 4,921 crore vs Rs 3,178 crore (+55% YoY).


31 Jul 20261:10 pm

Torrent Pharmaceuticals Share Price Gains 1.91% After Q1 Results

The Torrent Pharmaceuticals share price gain after Q1 results theme was in focus on Friday, with Torrent Pharmaceuticals shares moving 1.91% to Rs 4,965.00, from a previous close of Rs 4,872.10, after the company reported its results for the quarter ended June 2026.

Torrent Pharmaceuticals reported a profit after tax of Rs 566 crore for Q1 FY27, against Rs 548 crore in the year-ago quarter, a change of +3.3%. Revenue for the quarter stood at Rs 4,921 crore, compared with Rs 3,178 crore a year earlier, a change of +55%.

Click Here – Get Free Investment Predictions

Torrent Pharmaceuticals Q1 FY27 Results: Key Numbers

Metric Q1 FY27 Q1 FY26 YoY Change
Profit After Tax Rs 566 crore Rs 548 crore +3.3%
Revenue Rs 4,921 crore Rs 3,178 crore +55%

Why Torrent Pharmaceuticals Shares Moved 1.91% Today

Check the Univest Screener for sector-linked stocks

Revenue jumped sharply on the JB Pharma acquisition and strong India business, with margin building offset by integration and one-off costs.

About Torrent Pharmaceuticals

Ahmedabad-based pharma major ranked among India's top companies in cardiac, GI and CNS therapies.

Download the Univest iOS App or Univest Android App to track Torrent Pharmaceuticals's stock price and quarterly results.

What to Watch Going Forward

Investors tracking Torrent Pharmaceuticals should watch management commentary on demand trends, cost pressures and full-year guidance in the coming quarters, since forward-looking statements often matter as much as the headline quarterly numbers for how the stock trades over the following weeks.

Conclusion

The Torrent Pharmaceuticals share price gain after Q1 results move reflects the market's reaction to the company's latest quarterly performance. Investors should evaluate the stock against its own growth trajectory and valuation, and consult a SEBI-registered financial advisor before making any investment decision.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Torrent pharmaceuticals share price gain after q1 results

Why did Torrent Pharmaceuticals share price gain after Q1 results?

Ans. Torrent Pharmaceuticals shares moved 1.91% after the company reported Q1 FY27 profit after tax of Rs 566 crore, a change of +3.3% from Rs 548 crore a year earlier, on revenue of Rs 4,921 crore.

What was Torrent Pharmaceuticals's profit in Q1 FY27?

Ans. Torrent Pharmaceuticals reported a profit after tax of Rs 566 crore for the quarter ended June 2026, compared with Rs 548 crore in the same quarter a year earlier.

What was Torrent Pharmaceuticals's revenue in Q1 FY27?

Ans. Torrent Pharmaceuticals's revenue for Q1 FY27 stood at Rs 4,921 crore, compared with Rs 3,178 crore a year earlier, a change of +55%.

What is Torrent Pharmaceuticals's current share price?

Ans. Torrent Pharmaceuticals shares were trading at Rs 4,965.00 today, gaining 1.91% from the previous close of Rs 4,872.10.

Should I buy Torrent Pharmaceuticals shares after the Q1 results move?

Ans. Investment decisions should be based on individual research and risk appetite; consult a SEBI-registered financial advisor before buying or selling shares after any results-driven move.

Where can I track Torrent Pharmaceuticals's live share price?

Ans. Torrent Pharmaceuticals's live share price and quarterly result updates can be tracked on the Univest platform alongside SEBI-registered research.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down